Fredun Pharmaceuticals Reports Stellar Q1 FY27 Performance; Revenue Jumps 90%, Profit Rises 95% YoY
Mumbai, August 6, 2026 — Fredun Pharmaceuticals Limited, a major pharmaceutical formulation manufacturing company in India, has announced its unaudited financial results for the first quarter (Q1) of Fiscal Year 2027 (FY27). The Company offers a diversified portfolio that encompasses generics, nutraceuticals, cosmeceuticals, mobility solutions, and animal healthcare products.The Q1 FY27 results highlight robust growth across key performance indicators, as detailed in the financial summary below:Particulars ( ₹ Cr)Q1 FY27Q1 FY26YoY GrowthTotal Income228.25119.8690.44%EBITDA32.7816.9992.90%EBITDA Margin (%)14.36%14.18%18 Bps...